Clinical Trial Update: An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder. [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial evaluating naltrexone in adults with Attention Deficit Hyperactivity Disorder; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-09-20